Evidence map›Paper›PMID 25385587›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2014

Potential function for the Huntingtin protein as a scaffold for selective autophagy.

Joseph Ochaba, Tamás Lukacsovich, George Csikos, Shuqiu Zheng, Julia Margulis, Lisa Salazar, Kai Mao, Alice L Lau, Sylvia Y Yeung, Sandrine Humbert and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 179 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
179citing papers in PubMed, 1 pooled it
15.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

179 citing papers in PubMed, 1 synthesis or guideline pooled it, 296 citations in OpenAlex.

  1. Guideline
  2. Review
  3. Article
  4. Review
  5. Review
  6. ALS and Huntington Disease: Unraveling the Connections between TDP-43 and Huntingtin.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2026
    Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Reduced Palmitoylation of SQSTM1/p62 in Huntington Disease Is Associated With Impaired Autophagy.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  19. Article
  20. Review

119 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 8 institutions in 4 countries.

Joseph OchabaDepartment of Neurobiology and Behavior, Institute for Memory Impairments and Neurological Disorders, University of California, Irvine, CA 92697;
Tamás LukacsovichDepartment of Developmental and Cell Biology.
George CsikosDepartment of Anatomy, Cell, and Developmental Biology, Eötvös Loránd University, H-1117 Budapest, Hungary;
Shuqiu ZhengDepartment of Neuroscience, University of Virginia, Charlottesville, VA 22908;
Julia MargulisDepartment of Neurology and Department of Physiology, Gladstone Institute of Neurological Disease, Taube-Koret Center for Huntington's Disease Research, University of California, San Francisco, CA 94158;
Lisa SalazarDepartment of Psychiatry and Human Behavior.
Kai MaoDepartment of Molecular, Cellular, and Developmental Biology, and Department of Biological Chemistry, Life Sciences Institute, University of Michigan, Ann Arbor, MI 48109;
Alice L LauDepartment of Psychiatry and Human Behavior.
Sylvia Y YeungDepartment of Psychiatry and Human Behavior.
Sandrine HumbertInstitut Curie, Orsay 91405, France; and.
Frédéric SaudouInstitut Curie, Orsay 91405, France; and.
Daniel J KlionskyDepartment of Molecular, Cellular, and Developmental Biology, and Department of Biological Chemistry, Life Sciences Institute, University of Michigan, Ann Arbor, MI 48109;
Steven FinkbeinerDepartment of Neurology and Department of Physiology, Gladstone Institute of Neurological Disease, Taube-Koret Center for Huntington's Disease Research, University of California, San Francisco, CA 94158;
Scott O ZeitlinDepartment of Neuroscience, University of Virginia, Charlottesville, VA 22908;
J Lawrence MarshDepartment of Developmental and Cell Biology.
David E HousmanDepartment of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139 dhousman@mit.edu jssteffa@uci.edu.
Leslie M ThompsonDepartment of Neurobiology and Behavior, Institute for Memory Impairments and Neurological Disorders, University of California, Irvine, CA 92697; Department of Psychiatry and Human Behavior.
Joan S SteffanInstitute for Memory Impairments and Neurological Disorders, University of California, Irvine, CA 92697; Department of Psychiatry and Human Behavior, dhousman@mit.edu jssteffa@uci.edu.
Gladstone Institutes · USInstitut Curie · FRUniversity of California, Irvine · USUniversity of Michigan–Ann Arbor · USUniversity of Virginia · USEötvös Loránd University · HUInstitute of Neurobiology · BGMassachusetts Institute of Technology · US

Funding

ALTERNATIVE VACUOLAR TARGETING MECHANISMS IN YEASTR01GM053396 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KLIONSKY, DANIEL J. · 1995 to 2018
$12.1M
MECHANISMS OF HUNTINGTIN-INDUCED NEURODEGENERATIONR01NS039074 · NINDS · J. DAVID GLADSTONE INSTITUTES · PI FINKBEINER, STEVEN M · 2000 to 2017
$5.4M
Role of protein acetylation in Huntington's diseaseR01NS045283 · NINDS · UNIVERSITY OF CALIFORNIA-IRVINE · PI MARSH, J LAWRENCE · 2003 to 2014
$3.6M
Loss-of-function mechanisms in Huntington's DiseaseR01NS043466 · NINDS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI ZEITLIN, SCOTT · 2003 to 2013
$2.9M
Pathogenic Impact of SUMO modification in Huntington's diseaseR01NS052789 · NINDS · UNIVERSITY OF CALIFORNIA-IRVINE · PI THOMPSON, LESLIE MICHELS · 2006 to 2010
$1.9M
Pathogenic impact of Huntington phosphorylation in Huntington's DiseaseR01NS072453 · NINDS · UNIVERSITY OF CALIFORNIA-IRVINE · PI STEFFAN, JOAN SAWYER · 2012 to 2015
$1.3M
Loss-of-function mechanisms in Huntington's diseaseR56NS043466 · NINDS · UNIVERSITY OF VIRGINIA · PI ZEITLIN, SCOTT · 2008 to 2008
$341k
NIGMS NIH HHS R01 GM053396NINDS NIH HHS R01 NS039074NINDS NIH HHS R01 NS043466NINDS NIH HHS R01 NS045283NINDS NIH HHS R01 NS052789NINDS NIH HHS R01 NS072453NINDS NIH HHS R56 NS043466
6 · The paper itself

Abstract

Although dominant gain-of-function triplet repeat expansions in the Huntingtin (HTT) gene are the underlying cause of Huntington disease (HD), understanding the normal functions of nonmutant HTT protein has remained a challenge. We report here findings that suggest that HTT plays a significant role in selective autophagy. Loss of HTT function in Drosophila disrupts starvation-induced autophagy in larvae and conditional knockout of HTT in the mouse CNS causes characteristic cellular hallmarks of disrupted autophagy, including an accumulation of striatal p62/SQSTM1 over time. We observe that specific domains of HTT have structural similarities to yeast Atg proteins that function in selective autophagy, and in particular that the C-terminal domain of HTT shares structural similarity to yeast Atg11, an autophagic scaffold protein. To explore possible functional similarity between HTT and Atg11, we investigated whether the C-terminal domain of HTT interacts with mammalian counterparts of yeast Atg11-interacting proteins. Strikingly, this domain of HTT coimmunoprecipitates with several key Atg11 interactors, including the Atg1/Unc-51-like autophagy activating kinase 1 kinase complex, autophagic receptor proteins, and mammalian Atg8 homologs. Mutation of a phylogenetically conserved WXXL domain in a C-terminal HTT fragment reduces coprecipitation with mammalian Atg8 homolog GABARAPL1, suggesting a direct interaction. Collectively, these data support a possible central role for HTT as an Atg11-like scaffold protein. These findings have relevance to both mechanisms of disease pathogenesis and to therapeutic intervention strategies that reduce levels of both mutant and normal HTT.

Indexed as

AutophagyAnimalsAnimals, Genetically ModifiedDrosophilaDrosophila ProteinsHuntingtin ProteinMiceMicrotubule-Associated ProteinsDrosophila ProteinsHtt protein, DrosophilaHuntingtin ProteinMicrotubule-Associated ProteinsHuntingtinHuntington diseaseneurodegenerationpolyglutamineselective autophagy

Identifiers

PMID25385587
PMCPMC4250109
OpenAlexW2069686570

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.